Aixcrypto Holdings Inc (AIXC)

$1.19 -0.02 (-1.65%)
Market Cap 5.68M
Revenue (ttm) 0.00
Net Income (ttm) -6.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.01
Volume 35,396
Avg Vol 72,670
Day's Range N/A - N/A
Shares Out 5.16M
Stochastic %K 87%
Beta 0.38
Analysts Strong Buy
Price Target N/A

Company Profile

AIxCrypto Holdings, Inc. focuses on building an ecosystem that integrates Artificial Intelligence and blockchain while bridging Web2 and Web3. Its principal products include the BesTrade DeAI Agent and the AIxC ecosystem products. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. AIxCrypto Holdings, Inc. was founded in 1996 and is based in Carlsbad, California.

Industry: Software - Infrastructure
Sector: Technology
Phone: 760 452 8111
Address:
5857 Owens Avenue, Suite 300, Carlsbad, United States
Superbad787
Superbad787 Mar. 4 at 8:21 AM
$AIXC Tomorrow 🚀
0 · Reply
focafoca99
focafoca99 Mar. 3 at 10:57 PM
$AIXC let’s see if this news just released helps the stock move higher https://www.rapidticker.com/news/aixc-aixcrypto-co-ceo-jerry-wang-292961
0 · Reply
Universelaw
Universelaw Mar. 2 at 5:42 PM
$AIXC
0 · Reply
aafetygod
aafetygod Feb. 27 at 2:12 PM
$AIXC 0.5 waiting.
0 · Reply
Paraboljoker
Paraboljoker Feb. 26 at 11:05 PM
$AIXC $BNAI $NVDA $TSLA
1 · Reply
Paraboljoker
Paraboljoker Feb. 26 at 9:40 PM
$AIXC $BNAI $NVDA $TSLA 🤯👇🏼
0 · Reply
gofefego
gofefego Feb. 26 at 7:44 PM
$AIXC
0 · Reply
Universelaw
Universelaw Feb. 26 at 4:01 PM
$AIXC
0 · Reply
BullishAaFf
BullishAaFf Feb. 26 at 3:45 AM
$FFAI $AIXC
0 · Reply
6GodEnergy
6GodEnergy Feb. 25 at 7:07 PM
^ $AIXC $ANY.X $CLIK $CAVA >
0 · Reply
Latest News on AIXC
AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: Scaling the Ecosystem, Hub S2 Momentum, and AI Agent Framework Development

Mar 3, 2026, 5:46 PM EST - 6 days ago

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: Scaling the Ecosystem, Hub S2 Momentum, and AI Agent Framework Development

AIxC Hub Surpasses 4.8M Registered Wallets, Introduces New Season, and Announces "Agentir" for AI Agents

Feb 26, 2026, 1:35 AM EST - 12 days ago

AIxC Hub Surpasses 4.8M Registered Wallets, Introduces New Season, and Announces "Agentir" for AI Agents

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: Hub Season 2 Launch, and Social Growth Momentum

Feb 23, 2026, 1:29 AM EST - 15 days ago

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: Hub Season 2 Launch, and Social Growth Momentum

AIxCrypto Enters Strategic Partnership with Pinnacle Real Estate Group to Explore Core RWA Ecosystem Integration

Feb 20, 2026, 1:17 PM EST - 18 days ago

AIxCrypto Enters Strategic Partnership with Pinnacle Real Estate Group to Explore Core RWA Ecosystem Integration

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: BitMart Partnership, Hub Milestone, and Institutional & Industry Engagement

Feb 17, 2026, 5:10 AM EST - 21 days ago

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: BitMart Partnership, Hub Milestone, and Institutional & Industry Engagement

AIxC and BitMart Advance Co-Branded Virtual Card Partnership

Feb 12, 2026, 5:24 AM EST - 26 days ago

AIxC and BitMart Advance Co-Branded Virtual Card Partnership

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: $10 million FFAI Strategic Investment, 1M+ Wallets, and Sei Collaboration

Feb 2, 2026, 11:21 AM EST - 5 weeks ago

AIxCrypto Co-CEO Jerry Wang Shares Weekly Investor Update: $10 million FFAI Strategic Investment, 1M+ Wallets, and Sei Collaboration

AIxC and Sei Development Foundation Announce Strategic Collaboration

Feb 2, 2026, 11:21 AM EST - 5 weeks ago

AIxC and Sei Development Foundation Announce Strategic Collaboration

AIxCrypto Inc. Surpasses 1.1 Million Registered Wallets as AIxC Hub Launches "Tenki" Interactive Game

Jan 28, 2026, 3:01 PM EST - 5 weeks ago

AIxCrypto Inc. Surpasses 1.1 Million Registered Wallets as AIxC Hub Launches "Tenki" Interactive Game

AIXC Continues Strategic Corporate Expansion to Support Hyper-Growth of AIxC Hub Ecosystem

Jan 23, 2026, 12:24 AM EST - 6 weeks ago

AIXC Continues Strategic Corporate Expansion to Support Hyper-Growth of AIxC Hub Ecosystem

AIxC Announces AIxC Hub Exceeds 500,000 Registered Wallets in First Week Following Launch

Jan 15, 2026, 8:54 PM EST - 7 weeks ago

AIxC Announces AIxC Hub Exceeds 500,000 Registered Wallets in First Week Following Launch

AIxC to Advance Tokenization Strategy with Proposed Strategic Investment in Faraday Future

Jan 6, 2026, 1:39 PM EST - 2 months ago

AIxC to Advance Tokenization Strategy with Proposed Strategic Investment in Faraday Future

FFAI

AIxCrypto Establishes UAE Subsidiary and Obtains Web3 Operations License Approval to Support Global AI and Web3 Expansion

Dec 23, 2025, 9:00 AM EST - 2 months ago

AIxCrypto Establishes UAE Subsidiary and Obtains Web3 Operations License Approval to Support Global AI and Web3 Expansion

AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

Dec 17, 2025, 1:01 AM EST - 2 months ago

AIxC Appoints Andrew Grossman As Head of Legal Where He Will Direct the Company's Legal, Compliance, and Governance Strategy

FFAI

YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and Governance Framework

Dec 14, 2025, 11:44 PM EST - 3 months ago

YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and Governance Framework

FFAI

AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its "Three Driving Forces" Strategy to Become the No.1 Gateway to AI Web3 and a Bridge Between Web2 and Web3

Nov 20, 2025, 12:36 PM EST - 3 months ago

AIxCrypto Rebrands and Begins Trading Under New Ticker AIXC, Advancing Its "Three Driving Forces" Strategy to Become the No.1 Gateway to AI Web3 and a Bridge Between Web2 and Web3

Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy

Nov 16, 2025, 4:10 PM EST - 4 months ago

Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. (Nasdaq: AIXC) Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

Oct 27, 2025, 11:57 PM EDT - 4 months ago

Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025

Qualigen Therapeutics (QLGN) Stock Soars 62% After-Hours On Partnership With BitGo To Build Multi-Asset Crypto Treasury

Oct 24, 2025, 3:12 AM EDT - 4 months ago

Qualigen Therapeutics (QLGN) Stock Soars 62% After-Hours On Partnership With BitGo To Build Multi-Asset Crypto Treasury

BTGO

Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation

Oct 23, 2025, 4:05 PM EDT - 4 months ago

Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation

Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?

Oct 12, 2025, 9:00 PM EDT - 5 months ago

Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Oct 6, 2025, 7:00 PM EDT - 5 months ago

Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition

Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)

Sep 30, 2025, 4:00 PM EDT - 5 months ago

Univest Securities, LLC Announces Closing of $41 Million Strategic Investment in Client Qualigen Therapeutics (NASDAQ: QLGN) from Client Faraday Future (NASDAQ: FFAI)

FFAI

Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto

Sep 30, 2025, 7:08 AM EDT - 5 months ago

Qualigen Therapeutics Announces Successful Closing of $41 Million PIPE Financing Led by Faraday Future, Accelerating New Business Transformation into Crypto

Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction

Sep 19, 2025, 6:01 PM EDT - 6 months ago

Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Jul 28, 2025, 12:41 PM EDT - 8 months ago

Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

May 19, 2025, 5:25 PM EDT - 10 months ago

Qualigen Therapeutics, Inc. receives expected notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

May 1, 2025, 4:20 PM EDT - 11 months ago

Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Nov 25, 2024, 5:00 PM EST - 1 year ago

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

Nov 1, 2024, 9:00 AM EDT - 1 year ago

Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024

Qualigen Therapeutics, Inc. Announces management changes.

Sep 26, 2024, 5:10 PM EDT - 1 year ago

Qualigen Therapeutics, Inc. Announces management changes.

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

Sep 20, 2024, 9:00 AM EDT - 1 year ago

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Sep 6, 2024, 5:00 PM EDT - 1 year ago

Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

Sep 6, 2024, 4:30 PM EDT - 1 year ago

Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

Sep 5, 2024, 9:00 AM EDT - 1 year ago

Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

May 30, 2024, 4:00 PM EDT - 1 year ago

Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

Apr 9, 2024, 8:00 AM EDT - 2 years ago

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

Nov 14, 2023, 4:30 PM EST - 2 years ago

Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Nov 7, 2023, 8:30 AM EST - 2 years ago

Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer

Oct 23, 2023, 8:30 AM EDT - 2 years ago

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at AACR Special Conference: Advances in Breast Cancer

Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023

Sep 27, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics Presents Scientific Data on QN-302 at AACR Special Conference: Pancreatic Cancer 2023

Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors

Aug 17, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics Partners with TD2 for Phase 1 Clinical Development of QN-302 for the Treatment of Advanced or Metastatic Solid Tumors

Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023

Aug 15, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023

Qualigen Therapeutics Announces US FDA IND Clearance to Initiate Phase 1 Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Aug 1, 2023, 8:30 AM EDT - 2 years ago

Qualigen Therapeutics Announces US FDA IND Clearance to Initiate Phase 1 Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors

Qualigen Therapeutics Divests FastPack® Diagnostics Business

Jul 24, 2023, 8:15 AM EDT - 2 years ago

Qualigen Therapeutics Divests FastPack® Diagnostics Business

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Jun 5, 2023, 8:15 AM EDT - 3 years ago

Poster Highlighting Qualigen Therapeutics' Pan-RAS Inhibitor Platform Presented at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Qualigen Therapeutics, Inc. Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

May 2, 2023, 4:30 PM EDT - 3 years ago

Qualigen Therapeutics, Inc. Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update

Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

May 2, 2023, 8:15 AM EDT - 3 years ago

Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

Apr 21, 2023, 5:46 PM EDT - 3 years ago

Qualigen Therapeutics, Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing

Superbad787
Superbad787 Mar. 4 at 8:21 AM
$AIXC Tomorrow 🚀
0 · Reply
focafoca99
focafoca99 Mar. 3 at 10:57 PM
$AIXC let’s see if this news just released helps the stock move higher https://www.rapidticker.com/news/aixc-aixcrypto-co-ceo-jerry-wang-292961
0 · Reply
Universelaw
Universelaw Mar. 2 at 5:42 PM
$AIXC
0 · Reply
aafetygod
aafetygod Feb. 27 at 2:12 PM
$AIXC 0.5 waiting.
0 · Reply
Paraboljoker
Paraboljoker Feb. 26 at 11:05 PM
$AIXC $BNAI $NVDA $TSLA
1 · Reply
Paraboljoker
Paraboljoker Feb. 26 at 9:40 PM
$AIXC $BNAI $NVDA $TSLA 🤯👇🏼
0 · Reply
gofefego
gofefego Feb. 26 at 7:44 PM
$AIXC
0 · Reply
Universelaw
Universelaw Feb. 26 at 4:01 PM
$AIXC
0 · Reply
BullishAaFf
BullishAaFf Feb. 26 at 3:45 AM
$FFAI $AIXC
0 · Reply
6GodEnergy
6GodEnergy Feb. 25 at 7:07 PM
^ $AIXC $ANY.X $CLIK $CAVA >
0 · Reply
aafetygod
aafetygod Feb. 25 at 5:51 PM
$AIXC 80-90% run or 50% down.
0 · Reply
stogk
stogk Feb. 25 at 5:36 PM
$AIXC let's go
0 · Reply
gofefego
gofefego Feb. 25 at 4:37 PM
$AIXC let’s gooooo
0 · Reply
Triptrailz
Triptrailz Feb. 24 at 3:50 PM
$AIXC
0 · Reply
gofefego
gofefego Feb. 23 at 6:22 PM
$AIXC bought some
0 · Reply
Universelaw
Universelaw Feb. 23 at 6:22 PM
$AIXC
0 · Reply
Paraboljoker
Paraboljoker Feb. 23 at 3:24 PM
$AIXC $BNAI $NVDA $FFAI $GFAI LFG🤖
0 · Reply
Paraboljoker
Paraboljoker Feb. 23 at 3:02 PM
$FFAI $GFAI also keep n eye on $AIXC bottom here low 1.27
0 · Reply
Paraboljoker
Paraboljoker Feb. 23 at 2:42 PM
$AIXC New $BNAI ? AIXC many pr’s just in🗞️ $4.70 cash/s Trades $1.28 Nice setup👍 $NVDA $TSLA ww
0 · Reply
Paraboljoker
Paraboljoker Feb. 23 at 2:36 PM
$AIXC Bottom is in here 1.27$ $TIRX $ACLX lets move on☝️
1 · Reply
Paraboljoker
Paraboljoker Feb. 23 at 2:28 PM
$AIXC $RXT $SNES
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 22 at 1:01 PM
$AIXC RSI: 24.76, MACD: -0.2893 Vol: 0.35, MA20: 1.58, MA50: 2.15 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply